no antibiotic prophylaxis

PreclinicalSmall molecule

SShanghai Zhongshan Hospital

no antibiotic prophylaxis is one of 4 small molecule programs targeting Achalasia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AchalasiaActive, not recruiting

AchalasiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

5 competitors in Achalasia

#DrugCompanyPhaseTrials

Botox

RRevance Therapeutics, Inc.

Approved

2 2

Avycaz

PPhiladelphia Eye Associates

Approved

—3

Second Generation Cephalosporin

SShanghai Zhongshan Hospital

Preclinical

1 4

no antibiotic prophylaxis

SShanghai Zhongshan Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Achalasia1 trial

Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia

Unknown status·SShanghai Zhongshan Hospital·N/A·NCT01750385·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for no antibiotic prophylaxis. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — no antibiotic prophylaxis compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for no antibiotic prophylaxis. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shanghai Zhongshan Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SShanghai Zhongshan Hospital

no antibiotic prophylaxis

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Achalasia1 trial

References

Drug Info

Quick Facts

Related News